Pataday is expensive primarily because it’s a branded product from Alcon that dominates the eye allergy market, and its switch from prescription to over-the-counter status actually made it cost more for many people by removing insurance coverage. A 2.5 mL bottle of Pataday 0.2% carries a retail price around $37.58, which feels steep for a tiny bottle of eye drops you might need throughout allergy season.
Several factors stack on top of each other to keep that price high. Understanding them can help you figure out whether you’re overpaying and what alternatives exist.
The OTC Switch Removed Insurance Coverage
Pataday’s active ingredient, olopatadine, was prescription-only for years. Alcon sold it as Patanol (0.1%) and Pataday (0.2%), and most insurance plans covered at least one version with a copay. In July 2020, the FDA approved switching Pataday to over-the-counter status, including the Extra Strength 0.7% formulation, which had previously been sold as the prescription-only Pazeo.
That switch sounds like good news, but it created a pricing problem. Once a medication moves to OTC status, insurers stop covering it. The full retail cost shifts entirely to you. Your insurance premiums don’t go down to reflect this change, either. As one clinician noted after the approval, patients often lose access to medications when they go OTC because insurers use the switch as a reason to drop coverage. So a drug that might have cost you a $10 or $25 copay now costs the full shelf price out of pocket.
Brand Dominance Lets Alcon Set the Price
Alcon has positioned Pataday as the top eye allergy brand in the U.S. OTC market, and the company leans heavily on that status. Olopatadine is the most prescribed active ingredient for eye allergy relief, and Alcon markets Pataday Extra Strength as the first and only once-daily drop offering 24 hours of relief without a prescription. That kind of positioning gives Alcon significant pricing power. When consumers walk into a pharmacy looking for allergy eye drops, Pataday sits at the top of the shelf with name recognition that competitors can’t match.
Building and maintaining that brand recognition costs money. Alcon invests in advertising, packaging, and retail placement. Those costs get baked into what you pay per bottle. Generic olopatadine exists in prescription form from manufacturers like Apotex, Glenmark, and Sandoz, but the OTC retail shelf is where most people encounter the product now, and brand-name Pataday dominates that space.
Small Bottles, High Per-Unit Cost
Eye drop bottles are tiny. A standard Pataday bottle holds just 2.5 mL of solution. That’s roughly 30 to 45 drops depending on technique, which means a single bottle might last a few weeks if you’re using it daily in both eyes. The small volume makes the price feel especially painful because you’re paying nearly $40 for something that barely covers a month of allergy season.
The container itself uses Alcon’s proprietary DROP-TAINER system, which is designed for consistent drop delivery. It’s not groundbreaking technology, but proprietary packaging does add manufacturing cost compared to a basic squeeze bottle. When you spread that cost across 2.5 mL, it matters.
Cheaper Alternatives Work Similarly
Here’s the part that might frustrate you most: cheaper options perform about as well for most people. Ketotifen (sold OTC as Zaditor or Alaway) typically costs $8 to $15 for the same size bottle. Clinical trials comparing ketotifen and olopatadine found both drugs reduced itching and tearing more effectively than artificial tears, and both suppressed inflammatory markers on the eye’s surface at similar rates. Neither drug showed a significant advantage over the other for redness, swelling, or puffiness.
The main practical difference is dosing frequency. Ketotifen is usually used twice daily, while Pataday 0.2% is once daily and the Extra Strength 0.7% version claims 24-hour relief from a single drop. If once-daily dosing matters to you, that convenience is part of what you’re paying for. But if you don’t mind using drops morning and evening, ketotifen delivers comparable relief at a fraction of the cost.
How to Pay Less for Pataday
If you specifically want olopatadine, you have options to bring the price down. Pharmacy discount tools like GoodRx can drop the cost of Pataday 0.2% from nearly $38 to as low as $3.40 at some pharmacies. That’s a dramatic difference, and it’s worth checking before you pay full retail. Store-brand versions of olopatadine eye drops have also started appearing at major retailers, often priced 30 to 50 percent below the Pataday label for the same active ingredient at the same concentration.
If you have a flexible spending account or health savings account, OTC eye allergy drops generally qualify as eligible expenses. That won’t change the sticker price, but it lets you pay with pre-tax dollars. For people who used to get prescription olopatadine covered by insurance, asking your doctor to write a prescription for generic olopatadine (rather than buying OTC Pataday) may still be covered by some plans, though this varies widely by insurer.
The bottom line is that Pataday’s price reflects brand power, marketing investment, and the loss of insurance coverage after the OTC switch, not a dramatic difference in what’s inside the bottle compared to cheaper alternatives. For most seasonal allergy sufferers, a $10 bottle of ketotifen or a discounted generic olopatadine will do the same job.